Alerts will be sent to your verified email
Verify Email
VCL
|
Vaxtex Cotfab
|
Welcure Drugs&Pharma
|
Marg Techno
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
5.2 % | 45.81 % | 4.45 % |
|
5yr average Equity Multiplier
|
2.59 | -0.38 | 4.06 |
|
5yr Average Asset Turnover Ratio
|
1.07 | 0.25 | 0.16 |
|
5yr Avg Net Profit Margin
|
-6.35 % | -80.17 % | 6.94 % |
|
Price to Book
|
2.08 | 0.27 | 2.8 |
|
P/E
|
5.92 | 1.01 | 62.04 |
|
5yr Avg Cash Conversion Cycle
|
-264.46 Days | 2364.01 Days | 0.0 |
|
Inventory Days
|
18.98 Days | 20.66 Days | 0.0 |
|
Days Receivable
|
1031.48 Days | 1232.42 Days | 0.0 |
|
Days Payable
|
374.46 Days | 0.0 | 0.0 |
|
5yr Average Interest Coverage Ratio
|
-24.33 | -2.67 | 1.23 |
|
5yr Avg ROCE
|
-0.34 % | -7.19 % | 31.17 % |
|
5yr Avg Operating Profit Margin
|
-12.87 % | -81.01 % | 51.63 % |
|
5 yr average Debt to Equity
|
0.66 | -0.35 | 2.92 |
|
5yr CAGR Net Profit
|
37.35 % | -2.01 % | 8.71 % |
|
5yr Average Return on Assets
|
-1.52 % | -1.33 % | 1.09 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.84 % | 0.0 | 43.66 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-35.44 % | 0.0 | -29.11 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Vaxtex Cotfab
|
Welcure Drugs&Pharma
|
Marg Techno
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|